Hidalgo County Health Department to Discontinue Releasing COVID-19 Numbers

Translate to Spanish or other 102 languages!

In the latest sign that the COVID-19 pandemic is evolving into an endemic, the Hidalgo County Department of Health and Human Services will discontinue its three-year-long practice of releasing to the media and the public the latest numbers of those infected or who have perished because of the disease. Image for illustration purposes
In the latest sign that the COVID-19 pandemic is evolving into an endemic, the Hidalgo County Department of Health and Human Services will discontinue its three-year-long practice of releasing to the media and the public the latest numbers of those infected or who have perished because of the disease. Image for illustration purposes
- Advertisement -

EDINBURG – In the latest sign that the COVID-19 pandemic is evolving into an endemic, the Hidalgo County Department of Health and Human Services will discontinue its three-year-long practice of releasing to the media and the public the latest numbers of those infected or who have perished because of the disease.

The move by the health department comes in response to new guidelines provided by the Texas Department of State Health Services, which has advised counties statewide that they no longer must provide COVID-19 data to the state.

“Hidalgo County will continue to track COVID cases as it does with the flu and other transmissible diseases,” said Eduardo Olivarez, chief administrative officer for the Department of Health and Human Services. “But because of the new state guidelines, we will no longer be issuing our weekly news releases with an update of these numbers. This is another sign that COVID is considered more endemic than pandemic, which means it is a disease that will continue to be with us, but one that health officials are in a better position to treat because of newly developed vaccines and treatment protocols that did not exist when the pandemic emerged.”

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.

STHS Heart Ranks Among Nation’s Top Hospitals for Heart Attack Care

Every year, more than 800,000 people in the United States suffer a heart attack, according to the Centers for Disease Control and Prevention, an event that occurs approximately every 40 seconds.

DHR Health Burn Surgeon Urges Public to Avoid Preventable Risks

Many of the most serious burn and trauma injuries can be prevented by avoiding unnecessary risks, according to Dr. R. Dewayne Edwards, chief burn surgeon, surgical critical care and trauma surgeon at DHR Health, who said public awareness and timely medical care remain essential to improving patient outcomes.

Endocrine Society Outlines Strict Rules for Safe Testosterone Therapy

The Society’s Clinical Practice Guideline on testosterone replacement therapy in men with hypogonadism offers recommendations on appropriate testing and prescribing practices. 
- Advertisement -